nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—ALB—Auranofin—psoriatic arthritis	0.174	0.248	CbGbCtD
Fluoxetine—ALB—Prednisone—psoriatic arthritis	0.0554	0.079	CbGbCtD
Fluoxetine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0479	0.0682	CbGbCtD
Fluoxetine—CYP2C19—Prednisone—psoriatic arthritis	0.0359	0.0512	CbGbCtD
Fluoxetine—CYP2B6—Dexamethasone—psoriatic arthritis	0.0353	0.0503	CbGbCtD
Fluoxetine—ABCB1—Betamethasone—psoriatic arthritis	0.0311	0.0444	CbGbCtD
Fluoxetine—ABCB1—Prednisolone—psoriatic arthritis	0.0307	0.0438	CbGbCtD
Fluoxetine—ABCB1—Prednisone—psoriatic arthritis	0.029	0.0413	CbGbCtD
Fluoxetine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0287	0.0409	CbGbCtD
Fluoxetine—CYP3A5—Dexamethasone—psoriatic arthritis	0.0278	0.0396	CbGbCtD
Fluoxetine—ALB—Methotrexate—psoriatic arthritis	0.0278	0.0396	CbGbCtD
Fluoxetine—CYP2C19—Dexamethasone—psoriatic arthritis	0.0224	0.032	CbGbCtD
Fluoxetine—CYP3A4—Triamcinolone—psoriatic arthritis	0.0217	0.031	CbGbCtD
Fluoxetine—CYP2C9—Dexamethasone—psoriatic arthritis	0.0186	0.0266	CbGbCtD
Fluoxetine—CYP3A4—Betamethasone—psoriatic arthritis	0.0186	0.0266	CbGbCtD
Fluoxetine—CYP3A4—Prednisolone—psoriatic arthritis	0.0184	0.0262	CbGbCtD
Fluoxetine—ABCB1—Dexamethasone—psoriatic arthritis	0.0181	0.0258	CbGbCtD
Fluoxetine—CYP3A4—Prednisone—psoriatic arthritis	0.0174	0.0248	CbGbCtD
Fluoxetine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0171	0.0243	CbGbCtD
Fluoxetine—ABCB1—Methotrexate—psoriatic arthritis	0.0145	0.0207	CbGbCtD
Fluoxetine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0108	0.0155	CbGbCtD
Fluoxetine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000169	0.000568	CcSEcCtD
Fluoxetine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000169	0.000568	CcSEcCtD
Fluoxetine—Malaise—Betamethasone—psoriatic arthritis	0.000169	0.000566	CcSEcCtD
Fluoxetine—Malaise—Dexamethasone—psoriatic arthritis	0.000169	0.000566	CcSEcCtD
Fluoxetine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000168	0.000564	CcSEcCtD
Fluoxetine—Vertigo—Dexamethasone—psoriatic arthritis	0.000168	0.000564	CcSEcCtD
Fluoxetine—Vertigo—Betamethasone—psoriatic arthritis	0.000168	0.000564	CcSEcCtD
Fluoxetine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000168	0.000563	CcSEcCtD
Fluoxetine—Syncope—Betamethasone—psoriatic arthritis	0.000168	0.000562	CcSEcCtD
Fluoxetine—Syncope—Dexamethasone—psoriatic arthritis	0.000168	0.000562	CcSEcCtD
Fluoxetine—Arrhythmia—Prednisone—psoriatic arthritis	0.000167	0.000561	CcSEcCtD
Fluoxetine—Infection—Triamcinolone—psoriatic arthritis	0.000167	0.00056	CcSEcCtD
Fluoxetine—Sweating—Methotrexate—psoriatic arthritis	0.000167	0.00056	CcSEcCtD
Fluoxetine—Infection—Methylprednisolone—psoriatic arthritis	0.000167	0.000559	CcSEcCtD
Fluoxetine—Haematuria—Methotrexate—psoriatic arthritis	0.000166	0.000557	CcSEcCtD
Fluoxetine—Shock—Triamcinolone—psoriatic arthritis	0.000166	0.000555	CcSEcCtD
Fluoxetine—Insomnia—Prednisolone—psoriatic arthritis	0.000166	0.000555	CcSEcCtD
Fluoxetine—Alopecia—Prednisone—psoriatic arthritis	0.000166	0.000554	CcSEcCtD
Fluoxetine—Shock—Methylprednisolone—psoriatic arthritis	0.000165	0.000554	CcSEcCtD
Fluoxetine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000165	0.000551	CcSEcCtD
Fluoxetine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000165	0.000551	CcSEcCtD
Fluoxetine—Epistaxis—Methotrexate—psoriatic arthritis	0.000164	0.000551	CcSEcCtD
Fluoxetine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000164	0.000551	CcSEcCtD
Fluoxetine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000164	0.000551	CcSEcCtD
Fluoxetine—Mental disorder—Prednisone—psoriatic arthritis	0.000164	0.00055	CcSEcCtD
Fluoxetine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000164	0.000549	CcSEcCtD
Fluoxetine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000163	0.000547	CcSEcCtD
Fluoxetine—Malnutrition—Prednisone—psoriatic arthritis	0.000163	0.000546	CcSEcCtD
Fluoxetine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000163	0.000545	CcSEcCtD
Fluoxetine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000162	0.000544	CcSEcCtD
Fluoxetine—Convulsion—Betamethasone—psoriatic arthritis	0.000162	0.000543	CcSEcCtD
Fluoxetine—Convulsion—Dexamethasone—psoriatic arthritis	0.000162	0.000543	CcSEcCtD
Fluoxetine—Hypertension—Betamethasone—psoriatic arthritis	0.000162	0.000542	CcSEcCtD
Fluoxetine—Hypertension—Dexamethasone—psoriatic arthritis	0.000162	0.000542	CcSEcCtD
Fluoxetine—Myalgia—Dexamethasone—psoriatic arthritis	0.000159	0.000534	CcSEcCtD
Fluoxetine—Myalgia—Betamethasone—psoriatic arthritis	0.000159	0.000534	CcSEcCtD
Fluoxetine—Anxiety—Betamethasone—psoriatic arthritis	0.000159	0.000532	CcSEcCtD
Fluoxetine—Anxiety—Dexamethasone—psoriatic arthritis	0.000159	0.000532	CcSEcCtD
Fluoxetine—Discomfort—Betamethasone—psoriatic arthritis	0.000157	0.000528	CcSEcCtD
Fluoxetine—Discomfort—Dexamethasone—psoriatic arthritis	0.000157	0.000528	CcSEcCtD
Fluoxetine—Haemoglobin—Methotrexate—psoriatic arthritis	0.000157	0.000527	CcSEcCtD
Fluoxetine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000157	0.000526	CcSEcCtD
Fluoxetine—Pain—Prednisolone—psoriatic arthritis	0.000157	0.000525	CcSEcCtD
Fluoxetine—Hepatitis—Methotrexate—psoriatic arthritis	0.000157	0.000524	CcSEcCtD
Fluoxetine—Haemorrhage—Methotrexate—psoriatic arthritis	0.000157	0.000524	CcSEcCtD
Fluoxetine—Pharyngitis—Methotrexate—psoriatic arthritis	0.000155	0.00052	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000153	0.000514	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000153	0.000513	CcSEcCtD
Fluoxetine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000153	0.000512	CcSEcCtD
Fluoxetine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000153	0.000512	CcSEcCtD
Fluoxetine—Insomnia—Triamcinolone—psoriatic arthritis	0.000152	0.00051	CcSEcCtD
Fluoxetine—Insomnia—Methylprednisolone—psoriatic arthritis	0.000152	0.000509	CcSEcCtD
Fluoxetine—Infection—Dexamethasone—psoriatic arthritis	0.000152	0.000509	CcSEcCtD
Fluoxetine—Infection—Betamethasone—psoriatic arthritis	0.000152	0.000509	CcSEcCtD
Fluoxetine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000151	0.000507	CcSEcCtD
Fluoxetine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000151	0.000507	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000151	0.000506	CcSEcCtD
Fluoxetine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000151	0.000505	CcSEcCtD
Fluoxetine—Visual impairment—Methotrexate—psoriatic arthritis	0.000151	0.000505	CcSEcCtD
Fluoxetine—Anaemia—Prednisone—psoriatic arthritis	0.000151	0.000505	CcSEcCtD
Fluoxetine—Shock—Betamethasone—psoriatic arthritis	0.00015	0.000504	CcSEcCtD
Fluoxetine—Shock—Dexamethasone—psoriatic arthritis	0.00015	0.000504	CcSEcCtD
Fluoxetine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00015	0.000503	CcSEcCtD
Fluoxetine—Agitation—Prednisone—psoriatic arthritis	0.00015	0.000502	CcSEcCtD
Fluoxetine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00015	0.000501	CcSEcCtD
Fluoxetine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00015	0.000501	CcSEcCtD
Fluoxetine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000149	0.0005	CcSEcCtD
Fluoxetine—Tachycardia—Betamethasone—psoriatic arthritis	0.000149	0.0005	CcSEcCtD
Fluoxetine—Angioedema—Prednisone—psoriatic arthritis	0.000149	0.000499	CcSEcCtD
Fluoxetine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000148	0.000497	CcSEcCtD
Fluoxetine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000148	0.000496	CcSEcCtD
Fluoxetine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000148	0.000495	CcSEcCtD
Fluoxetine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000148	0.000495	CcSEcCtD
Fluoxetine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000148	0.000495	CcSEcCtD
Fluoxetine—Malaise—Prednisone—psoriatic arthritis	0.000147	0.000493	CcSEcCtD
Fluoxetine—Vertigo—Prednisone—psoriatic arthritis	0.000146	0.000491	CcSEcCtD
Fluoxetine—Syncope—Prednisone—psoriatic arthritis	0.000146	0.00049	CcSEcCtD
Fluoxetine—Tinnitus—Methotrexate—psoriatic arthritis	0.000146	0.000489	CcSEcCtD
Fluoxetine—Anorexia—Dexamethasone—psoriatic arthritis	0.000146	0.000488	CcSEcCtD
Fluoxetine—Anorexia—Betamethasone—psoriatic arthritis	0.000146	0.000488	CcSEcCtD
Fluoxetine—Urticaria—Prednisolone—psoriatic arthritis	0.000145	0.000487	CcSEcCtD
Fluoxetine—Fatigue—Triamcinolone—psoriatic arthritis	0.000145	0.000486	CcSEcCtD
Fluoxetine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000145	0.000485	CcSEcCtD
Fluoxetine—Pain—Triamcinolone—psoriatic arthritis	0.000144	0.000482	CcSEcCtD
Fluoxetine—Loss of consciousness—Prednisone—psoriatic arthritis	0.000143	0.00048	CcSEcCtD
Fluoxetine—Hypotension—Dexamethasone—psoriatic arthritis	0.000143	0.000478	CcSEcCtD
Fluoxetine—Hypotension—Betamethasone—psoriatic arthritis	0.000143	0.000478	CcSEcCtD
Fluoxetine—Convulsion—Prednisone—psoriatic arthritis	0.000141	0.000473	CcSEcCtD
Fluoxetine—Hypertension—Prednisone—psoriatic arthritis	0.000141	0.000472	CcSEcCtD
Fluoxetine—Chills—Methotrexate—psoriatic arthritis	0.00014	0.000471	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000139	0.000466	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000139	0.000466	CcSEcCtD
Fluoxetine—Myalgia—Prednisone—psoriatic arthritis	0.000139	0.000465	CcSEcCtD
Fluoxetine—Arthralgia—Prednisone—psoriatic arthritis	0.000139	0.000465	CcSEcCtD
Fluoxetine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000139	0.000465	CcSEcCtD
Fluoxetine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000138	0.000464	CcSEcCtD
Fluoxetine—Anxiety—Prednisone—psoriatic arthritis	0.000138	0.000463	CcSEcCtD
Fluoxetine—Alopecia—Methotrexate—psoriatic arthritis	0.000138	0.000463	CcSEcCtD
Fluoxetine—Insomnia—Betamethasone—psoriatic arthritis	0.000138	0.000463	CcSEcCtD
Fluoxetine—Insomnia—Dexamethasone—psoriatic arthritis	0.000138	0.000463	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000138	0.000462	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000137	0.00046	CcSEcCtD
Fluoxetine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000137	0.00046	CcSEcCtD
Fluoxetine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000137	0.00046	CcSEcCtD
Fluoxetine—Discomfort—Prednisone—psoriatic arthritis	0.000137	0.000459	CcSEcCtD
Fluoxetine—Mental disorder—Methotrexate—psoriatic arthritis	0.000137	0.000459	CcSEcCtD
Fluoxetine—Malnutrition—Methotrexate—psoriatic arthritis	0.000136	0.000456	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000135	0.000452	CcSEcCtD
Fluoxetine—Dyspepsia—Betamethasone—psoriatic arthritis	0.000134	0.000451	CcSEcCtD
Fluoxetine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000134	0.000451	CcSEcCtD
Fluoxetine—Urticaria—Triamcinolone—psoriatic arthritis	0.000134	0.000448	CcSEcCtD
Fluoxetine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000133	0.000447	CcSEcCtD
Fluoxetine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000133	0.000447	CcSEcCtD
Fluoxetine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000133	0.000446	CcSEcCtD
Fluoxetine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000133	0.000446	CcSEcCtD
Fluoxetine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000133	0.000445	CcSEcCtD
Fluoxetine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000133	0.000445	CcSEcCtD
Fluoxetine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000133	0.000445	CcSEcCtD
Fluoxetine—Infection—Prednisone—psoriatic arthritis	0.000132	0.000443	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000132	0.000442	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000132	0.000442	CcSEcCtD
Fluoxetine—Back pain—Methotrexate—psoriatic arthritis	0.000132	0.000442	CcSEcCtD
Fluoxetine—Fatigue—Dexamethasone—psoriatic arthritis	0.000132	0.000441	CcSEcCtD
Fluoxetine—Fatigue—Betamethasone—psoriatic arthritis	0.000132	0.000441	CcSEcCtD
Fluoxetine—Shock—Prednisone—psoriatic arthritis	0.000131	0.000439	CcSEcCtD
Fluoxetine—Pain—Betamethasone—psoriatic arthritis	0.000131	0.000438	CcSEcCtD
Fluoxetine—Pain—Dexamethasone—psoriatic arthritis	0.000131	0.000438	CcSEcCtD
Fluoxetine—Tachycardia—Prednisone—psoriatic arthritis	0.00013	0.000435	CcSEcCtD
Fluoxetine—Skin disorder—Prednisone—psoriatic arthritis	0.000129	0.000433	CcSEcCtD
Fluoxetine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000129	0.000431	CcSEcCtD
Fluoxetine—Anorexia—Prednisone—psoriatic arthritis	0.000127	0.000425	CcSEcCtD
Fluoxetine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000126	0.000424	CcSEcCtD
Fluoxetine—Anaemia—Methotrexate—psoriatic arthritis	0.000126	0.000422	CcSEcCtD
Fluoxetine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000126	0.000422	CcSEcCtD
Fluoxetine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000126	0.000422	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000125	0.000419	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000125	0.000419	CcSEcCtD
Fluoxetine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000124	0.000416	CcSEcCtD
Fluoxetine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000124	0.000415	CcSEcCtD
Fluoxetine—Malaise—Methotrexate—psoriatic arthritis	0.000123	0.000412	CcSEcCtD
Fluoxetine—Vertigo—Methotrexate—psoriatic arthritis	0.000122	0.00041	CcSEcCtD
Fluoxetine—Leukopenia—Methotrexate—psoriatic arthritis	0.000122	0.000409	CcSEcCtD
Fluoxetine—Urticaria—Betamethasone—psoriatic arthritis	0.000121	0.000407	CcSEcCtD
Fluoxetine—Urticaria—Dexamethasone—psoriatic arthritis	0.000121	0.000407	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000121	0.000406	CcSEcCtD
Fluoxetine—Dizziness—Prednisolone—psoriatic arthritis	0.000121	0.000406	CcSEcCtD
Fluoxetine—Asthenia—Triamcinolone—psoriatic arthritis	0.000121	0.000405	CcSEcCtD
Fluoxetine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000121	0.000405	CcSEcCtD
Fluoxetine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000121	0.000405	CcSEcCtD
Fluoxetine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000121	0.000405	CcSEcCtD
Fluoxetine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000121	0.000405	CcSEcCtD
Fluoxetine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000121	0.000404	CcSEcCtD
Fluoxetine—Insomnia—Prednisone—psoriatic arthritis	0.00012	0.000403	CcSEcCtD
Fluoxetine—Paraesthesia—Prednisone—psoriatic arthritis	0.000119	0.0004	CcSEcCtD
Fluoxetine—Pruritus—Triamcinolone—psoriatic arthritis	0.000119	0.000399	CcSEcCtD
Fluoxetine—Cough—Methotrexate—psoriatic arthritis	0.000119	0.000398	CcSEcCtD
Fluoxetine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000119	0.000398	CcSEcCtD
Fluoxetine—Convulsion—Methotrexate—psoriatic arthritis	0.000118	0.000396	CcSEcCtD
Fluoxetine—Dyspepsia—Prednisone—psoriatic arthritis	0.000117	0.000392	CcSEcCtD
Fluoxetine—Myalgia—Methotrexate—psoriatic arthritis	0.000116	0.000389	CcSEcCtD
Fluoxetine—Arthralgia—Methotrexate—psoriatic arthritis	0.000116	0.000389	CcSEcCtD
Fluoxetine—Chest pain—Methotrexate—psoriatic arthritis	0.000116	0.000389	CcSEcCtD
Fluoxetine—Decreased appetite—Prednisone—psoriatic arthritis	0.000116	0.000388	CcSEcCtD
Fluoxetine—Rash—Prednisolone—psoriatic arthritis	0.000115	0.000387	CcSEcCtD
Fluoxetine—Dermatitis—Prednisolone—psoriatic arthritis	0.000115	0.000386	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000115	0.000386	CcSEcCtD
Fluoxetine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000115	0.000385	CcSEcCtD
Fluoxetine—Fatigue—Prednisone—psoriatic arthritis	0.000115	0.000384	CcSEcCtD
Fluoxetine—Headache—Prednisolone—psoriatic arthritis	0.000115	0.000384	CcSEcCtD
Fluoxetine—Discomfort—Methotrexate—psoriatic arthritis	0.000115	0.000384	CcSEcCtD
Fluoxetine—Constipation—Prednisone—psoriatic arthritis	0.000114	0.000381	CcSEcCtD
Fluoxetine—Confusional state—Methotrexate—psoriatic arthritis	0.000112	0.000376	CcSEcCtD
Fluoxetine—Dizziness—Triamcinolone—psoriatic arthritis	0.000111	0.000373	CcSEcCtD
Fluoxetine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000111	0.000373	CcSEcCtD
Fluoxetine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000111	0.000372	CcSEcCtD
Fluoxetine—Infection—Methotrexate—psoriatic arthritis	0.00011	0.00037	CcSEcCtD
Fluoxetine—Feeling abnormal—Prednisone—psoriatic arthritis	0.00011	0.000367	CcSEcCtD
Fluoxetine—Asthenia—Betamethasone—psoriatic arthritis	0.00011	0.000367	CcSEcCtD
Fluoxetine—Asthenia—Dexamethasone—psoriatic arthritis	0.00011	0.000367	CcSEcCtD
Fluoxetine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000109	0.000365	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000109	0.000365	CcSEcCtD
Fluoxetine—Nausea—Prednisolone—psoriatic arthritis	0.000109	0.000364	CcSEcCtD
Fluoxetine—Pruritus—Dexamethasone—psoriatic arthritis	0.000108	0.000362	CcSEcCtD
Fluoxetine—Pruritus—Betamethasone—psoriatic arthritis	0.000108	0.000362	CcSEcCtD
Fluoxetine—Skin disorder—Methotrexate—psoriatic arthritis	0.000108	0.000362	CcSEcCtD
Fluoxetine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000108	0.00036	CcSEcCtD
Fluoxetine—Vomiting—Triamcinolone—psoriatic arthritis	0.000107	0.000359	CcSEcCtD
Fluoxetine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000107	0.000358	CcSEcCtD
Fluoxetine—Rash—Triamcinolone—psoriatic arthritis	0.000106	0.000356	CcSEcCtD
Fluoxetine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000106	0.000355	CcSEcCtD
Fluoxetine—Anorexia—Methotrexate—psoriatic arthritis	0.000106	0.000355	CcSEcCtD
Fluoxetine—Rash—Methylprednisolone—psoriatic arthritis	0.000106	0.000355	CcSEcCtD
Fluoxetine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000106	0.000355	CcSEcCtD
Fluoxetine—Urticaria—Prednisone—psoriatic arthritis	0.000106	0.000354	CcSEcCtD
Fluoxetine—Headache—Triamcinolone—psoriatic arthritis	0.000105	0.000353	CcSEcCtD
Fluoxetine—Headache—Methylprednisolone—psoriatic arthritis	0.000105	0.000353	CcSEcCtD
Fluoxetine—Body temperature increased—Prednisone—psoriatic arthritis	0.000105	0.000352	CcSEcCtD
Fluoxetine—Abdominal pain—Prednisone—psoriatic arthritis	0.000105	0.000352	CcSEcCtD
Fluoxetine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000105	0.00035	CcSEcCtD
Fluoxetine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000105	0.00035	CcSEcCtD
Fluoxetine—Hypotension—Methotrexate—psoriatic arthritis	0.000104	0.000348	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000101	0.000339	CcSEcCtD
Fluoxetine—Dizziness—Dexamethasone—psoriatic arthritis	0.000101	0.000338	CcSEcCtD
Fluoxetine—Dizziness—Betamethasone—psoriatic arthritis	0.000101	0.000338	CcSEcCtD
Fluoxetine—Insomnia—Methotrexate—psoriatic arthritis	0.000101	0.000337	CcSEcCtD
Fluoxetine—Nausea—Triamcinolone—psoriatic arthritis	0.0001	0.000335	CcSEcCtD
Fluoxetine—Paraesthesia—Methotrexate—psoriatic arthritis	9.99e-05	0.000335	CcSEcCtD
Fluoxetine—Nausea—Methylprednisolone—psoriatic arthritis	9.98e-05	0.000334	CcSEcCtD
Fluoxetine—Dyspnoea—Methotrexate—psoriatic arthritis	9.91e-05	0.000332	CcSEcCtD
Fluoxetine—Somnolence—Methotrexate—psoriatic arthritis	9.89e-05	0.000331	CcSEcCtD
Fluoxetine—Hypersensitivity—Prednisone—psoriatic arthritis	9.8e-05	0.000328	CcSEcCtD
Fluoxetine—Dyspepsia—Methotrexate—psoriatic arthritis	9.79e-05	0.000328	CcSEcCtD
Fluoxetine—Vomiting—Betamethasone—psoriatic arthritis	9.71e-05	0.000325	CcSEcCtD
Fluoxetine—Vomiting—Dexamethasone—psoriatic arthritis	9.71e-05	0.000325	CcSEcCtD
Fluoxetine—Decreased appetite—Methotrexate—psoriatic arthritis	9.67e-05	0.000324	CcSEcCtD
Fluoxetine—Rash—Dexamethasone—psoriatic arthritis	9.63e-05	0.000323	CcSEcCtD
Fluoxetine—Rash—Betamethasone—psoriatic arthritis	9.63e-05	0.000323	CcSEcCtD
Fluoxetine—Dermatitis—Dexamethasone—psoriatic arthritis	9.63e-05	0.000322	CcSEcCtD
Fluoxetine—Dermatitis—Betamethasone—psoriatic arthritis	9.63e-05	0.000322	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	9.6e-05	0.000322	CcSEcCtD
Fluoxetine—Fatigue—Methotrexate—psoriatic arthritis	9.59e-05	0.000321	CcSEcCtD
Fluoxetine—Headache—Betamethasone—psoriatic arthritis	9.57e-05	0.000321	CcSEcCtD
Fluoxetine—Headache—Dexamethasone—psoriatic arthritis	9.57e-05	0.000321	CcSEcCtD
Fluoxetine—Asthenia—Prednisone—psoriatic arthritis	9.55e-05	0.00032	CcSEcCtD
Fluoxetine—Pain—Methotrexate—psoriatic arthritis	9.51e-05	0.000319	CcSEcCtD
Fluoxetine—Pruritus—Prednisone—psoriatic arthritis	9.41e-05	0.000315	CcSEcCtD
Fluoxetine—Feeling abnormal—Methotrexate—psoriatic arthritis	9.16e-05	0.000307	CcSEcCtD
Fluoxetine—Diarrhoea—Prednisone—psoriatic arthritis	9.1e-05	0.000305	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	9.09e-05	0.000305	CcSEcCtD
Fluoxetine—Nausea—Betamethasone—psoriatic arthritis	9.08e-05	0.000304	CcSEcCtD
Fluoxetine—Nausea—Dexamethasone—psoriatic arthritis	9.08e-05	0.000304	CcSEcCtD
Fluoxetine—Urticaria—Methotrexate—psoriatic arthritis	8.83e-05	0.000296	CcSEcCtD
Fluoxetine—Dizziness—Prednisone—psoriatic arthritis	8.8e-05	0.000295	CcSEcCtD
Fluoxetine—Abdominal pain—Methotrexate—psoriatic arthritis	8.79e-05	0.000295	CcSEcCtD
Fluoxetine—Body temperature increased—Methotrexate—psoriatic arthritis	8.79e-05	0.000295	CcSEcCtD
Fluoxetine—Vomiting—Prednisone—psoriatic arthritis	8.46e-05	0.000283	CcSEcCtD
Fluoxetine—Rash—Prednisone—psoriatic arthritis	8.39e-05	0.000281	CcSEcCtD
Fluoxetine—Dermatitis—Prednisone—psoriatic arthritis	8.38e-05	0.000281	CcSEcCtD
Fluoxetine—Headache—Prednisone—psoriatic arthritis	8.34e-05	0.000279	CcSEcCtD
Fluoxetine—Hypersensitivity—Methotrexate—psoriatic arthritis	8.19e-05	0.000274	CcSEcCtD
Fluoxetine—Asthenia—Methotrexate—psoriatic arthritis	7.98e-05	0.000267	CcSEcCtD
Fluoxetine—Nausea—Prednisone—psoriatic arthritis	7.9e-05	0.000265	CcSEcCtD
Fluoxetine—Pruritus—Methotrexate—psoriatic arthritis	7.87e-05	0.000264	CcSEcCtD
Fluoxetine—Diarrhoea—Methotrexate—psoriatic arthritis	7.61e-05	0.000255	CcSEcCtD
Fluoxetine—Dizziness—Methotrexate—psoriatic arthritis	7.35e-05	0.000246	CcSEcCtD
Fluoxetine—Vomiting—Methotrexate—psoriatic arthritis	7.07e-05	0.000237	CcSEcCtD
Fluoxetine—Rash—Methotrexate—psoriatic arthritis	7.01e-05	0.000235	CcSEcCtD
Fluoxetine—Dermatitis—Methotrexate—psoriatic arthritis	7.01e-05	0.000235	CcSEcCtD
Fluoxetine—Headache—Methotrexate—psoriatic arthritis	6.97e-05	0.000233	CcSEcCtD
Fluoxetine—Nausea—Methotrexate—psoriatic arthritis	6.61e-05	0.000221	CcSEcCtD
